Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 26, 2023; 11(27): 6407-6414
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6407
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6407
Figure 1 Serum thyroglobulin levels can be used as an important biomarker to assess the risk of thyroid cancer in patients with thyroid nodules.
A: Comparison of gender composition between the two groups; B: Serum thyroglobulin (Tg) levels were significantly increased in thyroid patients; C: Serum Tg levels are highly sensitive to the diagnosis of thyroid cancer. ROC: Receiver operating characteristic; TSH: Thyroid-stimulating hormone.
- Citation: Shuai JH, Leng ZF, Wang P, Ji YC. Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery. World J Clin Cases 2023; 11(27): 6407-6414
- URL: https://www.wjgnet.com/2307-8960/full/v11/i27/6407.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i27.6407